Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide for use in an infant or young child for preventing a later in life health disorder by preventing premature adiposity rebound. The invention also relates to nutritional composition for use to promote healthy growth.
1. A method for preventing a later in life health disorder in an infant born to a mother carrying single nucleotide polymorphism (SNP) rs3894326, by preventing premature adiposity rebound, the method comprising administering an effective amount of a synthetic nutritional composition comprising diFucosyllactose (DFL) to the infant, wherein the DFL is 0.2 to 1.5 wt % of the synthetic nutritional composition by dry weight.
2. The method according to claim 1 , wherein the later in life health disorder is related to excessive fat mass accumulation.
3. The method according to claim 1 , wherein the synthetic nutritional composition further comprises at least one additional fucosylated oligosaccharide selected from the group consisting of 3′ fucosylated lactose (3′FL), Lacto-N-fucopentaose II (LNFP II), Lacto-N-fucopentaose III (LNFP III), Lacto-N-fucopentaose V (LNFP V), and combinations thereof.
4. The method according to claim 1 , wherein the health disorder is selected from the group consisting of overweight, obesity, type 2 diabetes, insulin resistance, hypertension, cardiovascular disease and metabolic syndrome.
5. The method according to claim 1 , wherein the synthetic nutritional composition further comprises at least one ingredient selected from the group consisting of galacto-oligosaccharides (GOS), fructo-oligosaccharides (FOS), xylo-oligosaccharides (XOS), inulin, polydextrose, sialylated oligosaccharides, sialic acid, fucose, N-acetylated oligosaccharides and combinations thereof.
6. The method according to claim 1 , wherein the synthetic nutritional composition further comprises at least one probiotic in an amount from 10 3 to 10 12 cfu/g of the synthetic nutritional composition by dry weight.
7. The method according to claim 1 , wherein the synthetic nutritional composition is in a form selected from the group consisting of an infant formula, a starter infant formula, a follow-on or follow-up infant formula, a baby food, an infant cereal composition, a growing-up milk, a fortifier and a supplement.
8. A method for preventing premature adiposity rebound in an infant born to a mother carrying single nucleotide polymorphism (SNP) rs3894326, the method comprising administering to the infant an effective amount of a synthetic nutritional composition comprising diFucosyllactose (DFL), wherein the DFL is 0.2 to 1.5 wt % of the synthetic nutritional composition by dry weight.
9. The method according to claim 1 , wherein the synthetic nutritional composition further comprises a source of lipids, a source of proteins and a source of carbohydrates.
10. The method according to claim 9 , wherein the source of lipids is selected from the group consisting essentially of palm oleic, sunflower oil, high oleic sunflower oil, coconut oil, canola oil, a mixture of poly-unsaturated fatty acids of arachidonic acid (ARA) and docosahexaenoic acid (DHA), milk fat and combinations thereof.
11. The method according to claim 1 , wherein the synthetic nutritional composition further comprises an ingredient selected from the group consisting of a vitamin, a mineral, an emulsifier, a stabilizer, a lactoferrin, a nucleotide, a nucleoside, a ganglioside, a polyamine and combinations thereof.
12. The method according to claim 1 , wherein the synthetic nutritional composition is in a physical form selected from the group consisting of a powder, a tablet, a capsule, a pastille and a liquid.
13. The method according to claim 1 , wherein the synthetic nutritional composition further comprises a source of prebiotics.